June 12, 2017

The team at PSNC has received a number of queries on the NHS Urgent Medicine Supply Advanced Service (NUMSAS) since the service has gone live. Below are some of the questions asked in recent weeks.

Q.How do pharmacies who are offering NUMSAS provide feedback on the service?
During the evaluation, contractors and NHS teams will have the opportunity to give feedback on NUMSAS. The process is under development and further guidance will be issued in due course.

Q.Some pharmacies on DoS are shown as company names instead of trading names; this is confusing especially when I want to forward patient details. How can I easily locate a pharmacy which is offering NUMSAS in these situations?
Within the DoS all pharmacies can be located by postcode. Use the patient’s location postcode to find the nearest pharmacy that is offering NUMSAS.

Q.How do I give feedback to the NHS 111 provider about the referral process?
All NHS 111 providers have a local feedback process established as part of their service. Contact your local NHS 111 provider to find out how feedback, including in relation to any patient safety incidents, should be provided.

Q.What should I do if a patient makes a second or third request for a supply of medicines or appliances through NUMSAS?
Pharmacists are expected to use their professional judgment about any repeated requests for urgent medicine or appliance supplies that are referred to their pharmacy. If there are any concerns, these should be raised with the patient’s GP as part of the feedback process and a review of the patient should be recommended. In some cases, it may be appropriate for the GP to add a Special Patient Note (SPN) to the patient’s care record to flag this issue to NHS 111.

Q.Does the notification of NHS England of a pharmacy contractor’s intention to start providing the service (via the form on the NHS BSA website) need to be undertaken for each pharmacy a contractor owns?
Yes. The notification may be undertaken centrally by one person on behalf of the contractor, but a notification needs to be made for each individual pharmacy that will be providing the service.

More FAQs on NUMSAS can be viewed at

Posted in:

More Latest News >

Trimovate cream supply issue

PSNC has become aware that the licensed Trimovate Cream manufactured by Ennogen Healthcare Ltd is currently unavailable. To meet patient...

GDPR webinar now on-demand

More than 600 people tuned in to PSNC’s recent webinars on complying with the General Data Protection Regulation (GDPR) and community pharmacy contractors can...

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and...